Hospitalized patients with COVID-19 receiving convalescent plasma did not gain a statistically significant benefit in time to clinical improvement in a small randomized trial conducted in Wuhan, China. But that may have been because the trial was stopped ...
from Google Alert - health https://ift.tt/2XZwa2x
via IFTTT
0 comments:
Post a Comment